Kde končí a začíná diagnóza Ewingova sarkomu - popis dvou neobvyklých kostních nádorů s translokací t(20;22)(EWSR1-NFATc2)
[Where does Ewing sarcoma end and begin - two cases of unusual bone tumors with t(20;22)(EWSR1-NFATc2) alteration]
Language Czech Country Czech Republic Media print
Document type Case Reports, Journal Article
PubMed
24758504
PII: 48478
- MeSH
- Diagnosis, Differential MeSH
- Child MeSH
- Adult MeSH
- Sarcoma, Ewing genetics pathology MeSH
- In Situ Hybridization, Fluorescence methods MeSH
- Immunohistochemistry MeSH
- Humans MeSH
- Neoplasm Recurrence, Local MeSH
- Bone Neoplasms genetics pathology MeSH
- RNA-Binding Protein EWS MeSH
- Calmodulin-Binding Proteins genetics MeSH
- RNA-Binding Proteins genetics MeSH
- NFATC Transcription Factors genetics MeSH
- Translocation, Genetic MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
- Names of Substances
- EWSR1 protein, human MeSH Browser
- NFATC2 protein, human MeSH Browser
- RNA-Binding Protein EWS MeSH
- Calmodulin-Binding Proteins MeSH
- RNA-Binding Proteins MeSH
- NFATC Transcription Factors MeSH
The authors present two cases of Ewing-like sarcoma of the humerus and femur of a 12-year-old boy and a 28-year-old male, respectively. Identical morphology in both tumors consisted of multiple solid nests with a mosaic collection of small, round, uniform cells with clear cytoplasm and no apparent nuclear atypia. A monotonous structural arrangement, including both rich vascularity of bordering septae and significant admixtures of eosinophil leucocytes, resulted in a final organoid "neuroendocrine-like" pattern. Immunohistochemistry revealed diffuse strong CD10, CD99 and CD138 positivity. Detailed molecular analysis in both tumors confirmed translocation t(20;22) resulting in an EWSR1-NFATc2 fusion gene. Additionally, this translocation was accompanied by amplification of the proximal part of the genes and surrounding areas. Clinically, both neoplasms behaved aggressively and they were primarily chemoresistant. Four years later, the patient with the lesion in the humerus developed a massive local recurrence with a disruption of osteosynthesis. The last follow-up disclosed suspicious metastatic deposits in the lung. The boy with the femoral tumor underwent a total femoral prosthesis and there are no signs of local or systemic recurrence after 11 months of follow-up. The authors discuss the taxonomic placement of these rare examples of Ewing-like sarcoma family in the light of new molecular discoveries.